ArticleBiomedicines2025
Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients.
Abstract read
In one paragraph
Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pharmacogenomic Insights: The Role of CYP2D6 Allelic Variants in Drug Metabolism Among COVID-19 Patients With Comorbidities.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
35 authors.
Alexandre Serra-LlovichFundació Docència i Recerca Mutua Terrassa, 08221 Terrassa, Spain.ORCID 0000-0001-8318-851X
Natalia CullellFundació Docència i Recerca Mutua Terrassa, 08221 Terrassa, Spain.
Olalla MaroñasFundación Pública Galega de Medicina Genómica (FPGMX), Centro Nacional de Genotipado (CEGEN), Servicio Gallego de Salud (SERGAS), 15706 Santiago de Compostela, Spain.
María José HerreroIIS La Fe, Plataforma de Farmacogenética, 43026 Valencia, Spain.ORCID 0000-0002-6042-4185
Raquel CruzCentre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-6964-8898
Berta AlmogueraCentre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Carmen AyusoCentre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-9242-7065
Rosario López-RodríguezCentre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-4713-0633
Elena Domínguez-GarridoUnidad Diagnóstico Molecular, Fundación Rioja Salud, 26006 La Rioja, Spain.
Rocio Ortiz-LopezTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud and Hospital San Jose TecSalud, Monterrey 64718, Mexico.
María Barreda-SánchezInstituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), 30120 Murcia, Spain.ORCID 0000-0002-4728-8174
Marta CortonCentre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
David DalmauFundació Docència i Recerca Mutua Terrassa, 08221 Terrassa, Spain.
Esther CalboHospital Universitario Mutua Terrassa, 08221 Terrassa, Spain.
Lucía Boix-PalopHospital Universitario Mutua Terrassa, 08221 Terrassa, Spain.
Beatriz DietlHospital Universitario Mutua Terrassa, 08221 Terrassa, Spain.ORCID 0000-0001-6011-6986
Anna SangilHospital Universitario Mutua Terrassa, 08221 Terrassa, Spain.
Almudena Gil-RodriguezGrupo de Farmacogenómica y Descubrimiento de Medicamentos (GenDeM), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.ORCID 0000-0002-7637-6915
Encarna Guillén-NavarroCentre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Esther ManceboDepartment of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0002-1535-9062
Saúl Lira-AlbarránLaboratorios MICROLAB Vios, Tegucigalpa 11101, Honduras.
Pablo MinguezCentre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-4099-9421
Estela Paz-ArtalDepartment of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Gladys G OliveraIIS La Fe, Plataforma de Farmacogenética, 43026 Valencia, Spain.ORCID 0000-0002-7698-2122
Sheila Recarey-RamaGrupo de Farmacogenómica y Descubrimiento de Medicamentos (GenDeM), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.ORCID 0009-0003-1623-1110
Luis SendraIIS La Fe, Plataforma de Farmacogenética, 43026 Valencia, Spain.ORCID 0000-0003-3176-9763
Enrique G ZucchetIIS La Fe, Plataforma de Farmacogenética, 43026 Valencia, Spain.
Miguel López de HerediaCentre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-2826-9565
Carlos FloresGenomics Division, Instituto Tecnológico y de Energías Renovables, 38600 Santa Cruz de Tenerife, Spain.ORCID 0000-0001-5352-069X
José A RianchoCentre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-0691-8755
Augusto Rojas-MartinezTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud and Hospital San Jose TecSalud, Monterrey 64718, Mexico.
Pablo LapunzinaFundación Pública Galega de Medicina Genómica (FPGMX), Centro Nacional de Genotipado (CEGEN), Servicio Gallego de Salud (SERGAS), 15706 Santiago de Compostela, Spain.ORCID 0000-0002-6324-4825
Ángel CarracedoFundación Pública Galega de Medicina Genómica (FPGMX), Centro Nacional de Genotipado (CEGEN), Servicio Gallego de Salud (SERGAS), 15706 Santiago de Compostela, Spain.ORCID 0000-0003-1085-8986
María J ArranzFundació Docència i Recerca Mutua Terrassa, 08221 Terrassa, Spain.ORCID 0000-0002-6757-9198
Scourge Cohort Group
Funding
European Union A way of making EuropeFundación Canaria de Investigación Sanitaria PIFIISC23/05Instituto de Salud Carlos III COV20_00622Instituto de Salud Carlos III JTC_2021; AC21_2/00039Instituto de Salud Carlos III PI20/00876Instituto de Salud Carlos III PT17/0019
Abstract
PubMed holds no abstract for this paper.
Indexed as
corticoidsimmunomodulatorspharmacogeneticsprecision medicineSARS-CoV-2
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.